1. Home
  2. JNJ
  3. JNJ News

Latest Johnson & Johnson (JNJ) News on November 6, 2025

Jim Cramer Just Couldn’t Help Himself When Talking About Kimberly-Clark (KMB)’s Kenvue Acquisition
JNJ

Insider Monkey

a day ago

Jim Cramer Just Couldn’t Help Himself When Talking About Kimberly-Clark (KMB)’s Kenvue Acquisition

Halozyme Beats on Q3 Earnings & Revenues, Raises 2025 View
JNJ

Zacks

2 days ago

Halozyme Beats on Q3 Earnings & Revenues, Raises 2025 View

Kimberly-Clark buys troubled Tylenol-maker Kenvue for $48.7bn
JNJ

Pharmaceutical Technology

2 days ago

Kimberly-Clark buys troubled Tylenol-maker Kenvue for $48.7bn

$144.85 Bn Disposable Medical Device Markets, 2025-2030: Opportunities in Innovation in Sustainable Materials, and Expansion in Emerging Markets and Underserved Regions
JNJ

GlobeNewswire

2 days ago

$144.85 Bn Disposable Medical Device Markets, 2025-2030: Opportunities in Innovation in Sustainable Materials, and Expansion in Emerging Markets and Underserved Regions

Kimberly-Clark Takeover Offers $48 Billion of Pain Relief to Tylenol-Maker Kenvue
JNJ

The Daily Upside

2 days ago

Kimberly-Clark Takeover Offers $48 Billion of Pain Relief to Tylenol-Maker Kenvue

Kimberly-Clark To Acquire Kenvue In $48.7 Billion Mega Deal
JNJ

GuruFocus.com

2 days ago

Kimberly-Clark To Acquire Kenvue In $48.7 Billion Mega Deal

Will Pipeline Milestones and New Oral Therapies Shift Johnson & Johnson's (JNJ) Growth Narrative?
JNJ

Simply Wall St.

2 days ago

Will Pipeline Milestones and New Oral Therapies Shift Johnson & Johnson's (JNJ) Growth Narrative?

Tulyp Medical Emerges From Sofinnova’s Medtech Accelerator and Announces FDA Submission Following Initial First-in-Human Use
JNJ

Business Wire

2 days ago

Tulyp Medical Emerges From Sofinnova’s Medtech Accelerator and Announces FDA Submission Following Initial First-in-Human Use

Alvotech faces FDA setback for its Simponi biosimilar AVT05
JNJ

Pharmaceutical Technology

2 days ago

Alvotech faces FDA setback for its Simponi biosimilar AVT05

JNJ

Morningstar Research

2 days ago

Analyst Report: Kenvue Inc.

Kimberly-Clark Stock Takes Biggest One-Day Hit Since Black Monday
JNJ

The Wall Street Journal

2 days ago

Kimberly-Clark Stock Takes Biggest One-Day Hit Since Black Monday

Kimberly-Clark to Buy Tylenol Maker Kenvue. Why Kimberly-Clark Stock Is Tanking.
JNJ

Barrons.com

3 days ago

Kimberly-Clark to Buy Tylenol Maker Kenvue. Why Kimberly-Clark Stock Is Tanking.

Kimberly-Clark to buy Kenvue, maker of Tylenol, in $48 billion deal
JNJ

USA TODAY

3 days ago

Kimberly-Clark to buy Kenvue, maker of Tylenol, in $48 billion deal

Kimberly-Clark buys Tylenol maker Kenvue for more than $48 billion
JNJ

Quartz

3 days ago

Kimberly-Clark buys Tylenol maker Kenvue for more than $48 billion

Kimberly-Clark Strikes $40 Billion Deal for Tylenol Maker Kenvue
JNJ

The Wall Street Journal

3 days ago

Kimberly-Clark Strikes $40 Billion Deal for Tylenol Maker Kenvue

Tylenol, Kleenex, Band-Aid and more put under one roof in $48.7 billion consumer brands deal
JNJ

Associated Press Finance

3 days ago

Tylenol, Kleenex, Band-Aid and more put under one roof in $48.7 billion consumer brands deal

Benitec Biopharma Announces Appointment of Sharon Mates Ph.D. to its Board of Directors
JNJ

GlobeNewswire

3 days ago

Benitec Biopharma Announces Appointment of Sharon Mates Ph.D. to its Board of Directors

Kimberly-Clark to Acquire Kenvue
JNJ

WWD

3 days ago

Kimberly-Clark to Acquire Kenvue

Japan Non-Invasive Aesthetic Treatment Market Analysis and Outlook 2025-2033 with City-Level Breakdowns by Procedure, Gender and End User
JNJ

GlobeNewswire

3 days ago

Japan Non-Invasive Aesthetic Treatment Market Analysis and Outlook 2025-2033 with City-Level Breakdowns by Procedure, Gender and End User

AbbVie Q3 Earnings & Sales Beat, 2025 EPS Outlook Raised
JNJ

Zacks

6 days ago

AbbVie Q3 Earnings & Sales Beat, 2025 EPS Outlook Raised

Should You Buy, Hold, or Sell BDTX Stock Ahead of Q3 Earnings?
JNJ

Zacks

6 days ago

Should You Buy, Hold, or Sell BDTX Stock Ahead of Q3 Earnings?

Appointment of Yves Decadt as Member of Poxel’s Board of Directors
JNJ

Business Wire

6 days ago

Appointment of Yves Decadt as Member of Poxel’s Board of Directors

I’m 65, itching to retire but only have $500K saved. I want $2K/month plus my Social Security — how can I swing this?
JNJ

Moneywise

6 days ago

I’m 65, itching to retire but only have $500K saved. I want $2K/month plus my Social Security — how can I swing this?

AbbVie Beats Third-Quarter Estimates. There’s More to the Drugmaker’s Earnings.
JNJ

Barrons.com

6 days ago

AbbVie Beats Third-Quarter Estimates. There’s More to the Drugmaker’s Earnings.

JNJ

MT Newswires

6 days ago

Nanobiotix to Receive Up to $71 Million in Royalty Financing From HealthCare Royalty

The Zacks Analyst Blog Highlights Broadcom, Johnson & Johnson, Palantir Technologies, Fossil Group and Moving iMage
JNJ

Zacks

6 days ago

The Zacks Analyst Blog Highlights Broadcom, Johnson & Johnson, Palantir Technologies, Fossil Group and Moving iMage

Top Analyst Reports for Broadcom, Johnson & Johnson and Palantir
JNJ

Zacks

6 days ago

Top Analyst Reports for Broadcom, Johnson & Johnson and Palantir

Bladder Cancer Market - Global and Regional Analysis and Forecast (2025-2035) Featuring Merck & Co., Bristol Myers Squibb, Astellas Pharma, AstraZeneca, and Johnson & Johnson
JNJ

GlobeNewswire

7 days ago

Bladder Cancer Market - Global and Regional Analysis and Forecast (2025-2035) Featuring Merck & Co., Bristol Myers Squibb, Astellas Pharma, AstraZeneca, and Johnson & Johnson

Here's Why Johnson & Johnson (JNJ) is a Strong Value Stock
JNJ

Zacks

7 days ago

Here's Why Johnson & Johnson (JNJ) is a Strong Value Stock

Bristol Myers Squibb Stock Rises After Solid Earnings. But These Problems Remain.
JNJ

Barrons.com

7 days ago

Bristol Myers Squibb Stock Rises After Solid Earnings. But These Problems Remain.

Merck & Co., Inc., Rahway, N.J., USA Announces Third-Quarter 2025 Financial Results
JNJ

Business Wire

7 days ago

Merck & Co., Inc., Rahway, N.J., USA Announces Third-Quarter 2025 Financial Results

Is Ulta Beauty's (ULTA) CFO Appointment a Signal for Change Amid Margin and Demand Concerns?
JNJ

Simply Wall St.

7 days ago

Is Ulta Beauty's (ULTA) CFO Appointment a Signal for Change Amid Margin and Demand Concerns?

GSK's Q3 Earnings & Sales Beat Estimates, Stock Up on Raised '25 View
JNJ

Zacks

8 days ago

GSK's Q3 Earnings & Sales Beat Estimates, Stock Up on Raised '25 View

JNJ

MT Newswires

8 days ago

Johnson & Johnson Plans Study Comparing Imaavy With Another FcRn Blocker

Johnson & Johnson announces first head-to-head study comparing IMAAVY™ with an alternative FcRn blocker in generalized myasthenia gravis (gMG) at AANEM Annual Meeting
JNJ

PR Newswire

8 days ago

Johnson & Johnson announces first head-to-head study comparing IMAAVY™ with an alternative FcRn blocker in generalized myasthenia gravis (gMG) at AANEM Annual Meeting

Freedom Capital Downgrades Johnson & Johnson (JNJ) to Hold Despite Strong Q3 Results
JNJ

Insider Monkey

8 days ago

Freedom Capital Downgrades Johnson & Johnson (JNJ) to Hold Despite Strong Q3 Results

Levin Papantonio Announces Jury Awards $20 Million Verdict in Talc Mesothelioma Case Casaretto Estate v. Johnson & Johnson
JNJ

GlobeNewswire

8 days ago

Levin Papantonio Announces Jury Awards $20 Million Verdict in Talc Mesothelioma Case Casaretto Estate v. Johnson & Johnson

Is Johnson & Johnson’s Share Price Justified After Recent Surge in 2025?
JNJ

Simply Wall St.

9 days ago

Is Johnson & Johnson’s Share Price Justified After Recent Surge in 2025?

Texas Suit Accuses Tylenol Maker of Hiding a Link to Autism
JNJ

The Wall Street Journal

9 days ago

Texas Suit Accuses Tylenol Maker of Hiding a Link to Autism

Tylenol Is Tied to Autism, Texas Claims in Suit. Kenvue Stock Shudders.
JNJ

Barrons.com

9 days ago

Tylenol Is Tied to Autism, Texas Claims in Suit. Kenvue Stock Shudders.

H.C. Wainwright Maintains a Buy on Halozyme Therapeutics (HALO), Keeps the PT at $90
JNJ

Insider Monkey

9 days ago

H.C. Wainwright Maintains a Buy on Halozyme Therapeutics (HALO), Keeps the PT at $90

Texas sues Kenvue and J&J, Truth Social to offer prediction markets
JNJ

Yahoo Finance Video

9 days ago

Texas sues Kenvue and J&J, Truth Social to offer prediction markets

As Dow Hits Record, High-Yield Dogs of the Dow Still a Bargain
JNJ

24/7 Wall St.

9 days ago

As Dow Hits Record, High-Yield Dogs of the Dow Still a Bargain

JNJ

MT Newswires

9 days ago

Update: Texas AG Sues Kenvue, Johnson & Johnson for Alleged Deceptive Marketing of Tylenol to Pregnant Women

Is Halozyme Stock a Portfolio Must-Have Ahead of Q3 Earnings?
JNJ

Zacks

10 days ago

Is Halozyme Stock a Portfolio Must-Have Ahead of Q3 Earnings?

What's in Store for These 5 Pharma Bigwigs This Earnings Season?
JNJ

Zacks

10 days ago

What's in Store for These 5 Pharma Bigwigs This Earnings Season?

3 Healthcare Stocks to Buy Hand Over Fist in October
JNJ

Motley Fool

10 days ago

3 Healthcare Stocks to Buy Hand Over Fist in October

Here's Why Johnson & Johnson (JNJ) is a Strong Momentum Stock
JNJ

Zacks

10 days ago

Here's Why Johnson & Johnson (JNJ) is a Strong Momentum Stock

JNJ vs. MRK: Which Blue-Chip Pharma Stock Should Be in Your Portfolio?
JNJ

Zacks

10 days ago

JNJ vs. MRK: Which Blue-Chip Pharma Stock Should Be in Your Portfolio?

JNJ

MT Newswires

10 days ago

Protagonist Therapeutics Says Icotrokinra Showed 'Meaningful' Outcomes in Ulcerative Colitis Phase 2 Trial

Johnson and Johnson to spin off orthopaedics market
JNJ

Medical Device Network

10 days ago

Johnson and Johnson to spin off orthopaedics market

JNJ

MT Newswires

10 days ago

Johnson & Johnson's Study Shows Clinically Meaningful Results for Icotrokinra in Ulcerative Colitis Patients

Got $1,000? 3 High-Yield Healthcare Stocks to Buy and Hold Forever.
JNJ

Motley Fool

11 days ago

Got $1,000? 3 High-Yield Healthcare Stocks to Buy and Hold Forever.

Johnson & Johnson (JNJ): Evaluating Valuation After Recent Share Gains and Growth Outlook
JNJ

Simply Wall St.

11 days ago

Johnson & Johnson (JNJ): Evaluating Valuation After Recent Share Gains and Growth Outlook

Published in The Lancet: Nipocalimab significantly decreased Sjögren's disease (SjD) activity and severity through substantial reduction in Sjögren's-related autoantibodies
JNJ

PR Newswire

12 days ago

Published in The Lancet: Nipocalimab significantly decreased Sjögren's disease (SjD) activity and severity through substantial reduction in Sjögren's-related autoantibodies

GSK Crumbles As Blood Cancer Comeback Falls Unexpectedly Short
JNJ

Investor's Business Daily

13 days ago

GSK Crumbles As Blood Cancer Comeback Falls Unexpectedly Short

Trade Truce Hope: How US-China Talks Could Boost Healthcare ETFs
JNJ

Zacks

13 days ago

Trade Truce Hope: How US-China Talks Could Boost Healthcare ETFs

Merck's Non-Oncology Drugs Q3 Performance: What to Expect
JNJ

Zacks

13 days ago

Merck's Non-Oncology Drugs Q3 Performance: What to Expect

JNJ

MT Newswires

13 days ago

Johnson & Johnson Says Two-Thirds of Patients in Phase-3 Psoriasis Study Displayed Clear or Almost Clear Skin

Icotrokinra long-term results affirm promise of targeted oral peptide with high rates of durable skin clearance and favorable safety profile in difficult-to-treat scalp and genital psoriasis
JNJ

PR Newswire

13 days ago

Icotrokinra long-term results affirm promise of targeted oral peptide with high rates of durable skin clearance and favorable safety profile in difficult-to-treat scalp and genital psoriasis

JNJ

MT Newswires

13 days ago

Nanobiotix Transfers Nanoray-312 Sponsorship to Johnson & Johnson

NANOBIOTIX Announces Updates to JNJ-1900 (NBTXR3) Clinical Program Following Transfer of Ongoing Phase 3 Head and Neck Cancer Trial Sponsorship and Operational Control
JNJ

GlobeNewswire

13 days ago

NANOBIOTIX Announces Updates to JNJ-1900 (NBTXR3) Clinical Program Following Transfer of Ongoing Phase 3 Head and Neck Cancer Trial Sponsorship and Operational Control

Will Higher Royalties From Partners Fuel HALO's Growth in H2 2025?
JNJ

Zacks

14 days ago

Will Higher Royalties From Partners Fuel HALO's Growth in H2 2025?

AngioInsight Appoints Medtech Veteran Shlomi Nachman to Board of Directors; Announces Series A Round to Accelerate AI-Driven Advancement in Cardiology
JNJ

Business Wire

14 days ago

AngioInsight Appoints Medtech Veteran Shlomi Nachman to Board of Directors; Announces Series A Round to Accelerate AI-Driven Advancement in Cardiology

GCC $1.25+ Bn Catheter Market Growth Trends and Forecast to 2033 Featuring Abbott, Edwards Lifesciences, BD and Co, Boston Scientific, Medtronic, Johnson & Johnson, Stryker, Teleflex
JNJ

GlobeNewswire

14 days ago

GCC $1.25+ Bn Catheter Market Growth Trends and Forecast to 2033 Featuring Abbott, Edwards Lifesciences, BD and Co, Boston Scientific, Medtronic, Johnson & Johnson, Stryker, Teleflex

Johnson & Johnson to Participate in the 7th Annual Wolfe Research Healthcare Conference
JNJ

Business Wire

15 days ago

Johnson & Johnson to Participate in the 7th Annual Wolfe Research Healthcare Conference

How the Narrative Around J&J Is Shifting After Recent Results and Analyst Upgrades
JNJ

Simply Wall St.

15 days ago

How the Narrative Around J&J Is Shifting After Recent Results and Analyst Upgrades

Tylenol-Maker Kenvue’s Stock Is Down 30% in 2025. Its Fate May Be in the FDA’s Hands.
JNJ

Barchart

15 days ago

Tylenol-Maker Kenvue’s Stock Is Down 30% in 2025. Its Fate May Be in the FDA’s Hands.

Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know
JNJ

Zacks

15 days ago

Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know

Fortune 500 Leaders Share AI-powered Supply Chain Excellence on Stage at OMP Conference
JNJ

ACCESS Newswire

15 days ago

Fortune 500 Leaders Share AI-powered Supply Chain Excellence on Stage at OMP Conference

Inspira Appoints Former Johnson & Johnson Senior Business Manager as VP of Global Sales and New Board Member from a Leading International Investment Firm
JNJ

GlobeNewswire

16 days ago

Inspira Appoints Former Johnson & Johnson Senior Business Manager as VP of Global Sales and New Board Member from a Leading International Investment Firm

Lenovo Ranks on Fast Company's Seventh Annual List of the 100 Best Workplaces for AI Innovators for the Second Year in a Row
JNJ

ACCESS Newswire

16 days ago

Lenovo Ranks on Fast Company's Seventh Annual List of the 100 Best Workplaces for AI Innovators for the Second Year in a Row

Johnson & Johnson Targets Accelerated Growth Across Segments in 2026
JNJ

Zacks

16 days ago

Johnson & Johnson Targets Accelerated Growth Across Segments in 2026

Inspira Appoints Former Johnson & Johnson Executive as VP of Global Sales and New Board Member from a Leading International Investment Firm
JNJ

GlobeNewswire

16 days ago

Inspira Appoints Former Johnson & Johnson Executive as VP of Global Sales and New Board Member from a Leading International Investment Firm

JNJ

MT Newswires

16 days ago

Johnson & Johnson Insider Sold Shares Worth $4,185,793, According to a Recent SEC Filing

Elon Musk takes shot at rival facing major problem
JNJ

TheStreet

17 days ago

Elon Musk takes shot at rival facing major problem

Goldman Sachs Reveals Sectors With Top 2026 Payouts: 5 Strong Buys
JNJ

24/7 Wall St.

17 days ago

Goldman Sachs Reveals Sectors With Top 2026 Payouts: 5 Strong Buys

Kenvue at the Cross-Road
JNJ

GuruFocus.com

17 days ago

Kenvue at the Cross-Road

3 Dividend Stocks With 5% (or Higher) Yields to Buy Hand Over Fist in October
JNJ

Motley Fool

17 days ago

3 Dividend Stocks With 5% (or Higher) Yields to Buy Hand Over Fist in October

JNJ

MT Newswires

17 days ago

Daiwa Securities Upgrades Johnson & Johnson to Outperform From Neutral, Adjusts PT to $203 From $170

JNJ

MT Newswires

17 days ago

Johnson & Johnson Reports 45% Response Rate for Subcutaneous Amivantamab in Head and Neck Cancer Study

Subcutaneous amivantamab delivers promising 45 percent overall response rate with median duration of 7.2 months in recurrent or metastatic head and neck cancer
JNJ

PR Newswire

18 days ago

Subcutaneous amivantamab delivers promising 45 percent overall response rate with median duration of 7.2 months in recurrent or metastatic head and neck cancer

JNJ

MT Newswires

20 days ago

S&P 500 Posts Weekly Gain on Tariff Optimism, Better-Than-Expected Earnings

J&J’s Tecvayli-Darzalex trumps SoC in multiple myeloma
JNJ

Clinical Trials Arena

20 days ago

J&J’s Tecvayli-Darzalex trumps SoC in multiple myeloma

Should You Buy, Sell or Hold J&J Stock After Robust Q3 Earnings?
JNJ

Zacks

20 days ago

Should You Buy, Sell or Hold J&J Stock After Robust Q3 Earnings?

Diorasis Therapeutics Welcomes Dr. Dimitri Azar to Its Board of Directors
JNJ

Business Wire

20 days ago

Diorasis Therapeutics Welcomes Dr. Dimitri Azar to Its Board of Directors

J&J Myeloma Combo Hits Late-Stage Goal
JNJ

GuruFocus.com

20 days ago

J&J Myeloma Combo Hits Late-Stage Goal

Earnings live: American Express beats estimates, EssilorLuxottica stock surges as focus turns to regional bank earnings
JNJ

Yahoo Finance

20 days ago

Earnings live: American Express beats estimates, EssilorLuxottica stock surges as focus turns to regional bank earnings

HistoSonics raises $250m to support commercial expansion
JNJ

Medical Device Network

20 days ago

HistoSonics raises $250m to support commercial expansion

Ulta Beauty names Christopher DelOrefice as new CFO
JNJ

Retail Insight Network

20 days ago

Ulta Beauty names Christopher DelOrefice as new CFO

JNJ

Morningstar Research

20 days ago

Analyst Report: Kenvue Inc.

Why Kenvue Stock Tumbled by 13% on Thursday
JNJ

Motley Fool

20 days ago

Why Kenvue Stock Tumbled by 13% on Thursday

Kenvue Stock Falls 13% in Its Worst Day on Record
JNJ

The Wall Street Journal

21 days ago

Kenvue Stock Falls 13% in Its Worst Day on Record

Ulta Beauty Names Christopher DelOrefice as Chief Financial Officer
JNJ

Business Wire

21 days ago

Ulta Beauty Names Christopher DelOrefice as Chief Financial Officer

JNJ

MT Newswires

21 days ago

Update: Johnson & Johnson Faces UK Lawsuit Over Talc Products

TECVAYLI® plus DARZALEX FASPRO® combination regimen significantly improves progression-free survival and overall survival versus standard of care
JNJ

PR Newswire

21 days ago

TECVAYLI® plus DARZALEX FASPRO® combination regimen significantly improves progression-free survival and overall survival versus standard of care

Earnings live: TSMC profit surges amid 'strong' AI demand, Charles Schwab stock ticks higher, United slips
JNJ

Yahoo Finance

21 days ago

Earnings live: TSMC profit surges amid 'strong' AI demand, Charles Schwab stock ticks higher, United slips

JNJ

MT Newswires

21 days ago

Johnson & Johnson Faces UK Lawsuit Over Talc Products

JNJ

MT Newswires

21 days ago

HSBC Adjusts Price Target on Johnson & Johnson to $215 From $210, Maintains Buy Rating

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.
JNJ

Motley Fool

21 days ago

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.

Share on Social Networks: